StockNews.com Begins Coverage on Retractable Technologies (NYSE:RVP)

Investment analysts at StockNews.com initiated coverage on shares of Retractable Technologies (NYSE:RVP) in a report released on Thursday. The brokerage set a “hold” rating on the stock.

Retractable Technologies Price Performance

Shares of NYSE:RVP opened at $1.08 on Thursday. Retractable Technologies has a 12 month low of $0.95 and a 12 month high of $1.85. The stock has a market cap of $32.34 million, a price-to-earnings ratio of -4.50 and a beta of 2.11. The stock’s 50 day moving average price is $1.19 and its 200 day moving average price is $1.16. The company has a debt-to-equity ratio of 0.01, a current ratio of 8.28 and a quick ratio of 6.41.

Institutional Investors Weigh In On Retractable Technologies

An institutional investor recently raised its position in Retractable Technologies stock. WealthTrust Axiom LLC raised its stake in Retractable Technologies, Inc. (NYSE:RVP) by 27.8% during the 3rd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 126,533 shares of the company’s stock after buying an additional 27,500 shares during the period. WealthTrust Axiom LLC owned approximately 0.42% of Retractable Technologies worth $151,000 as of its most recent filing with the SEC. Institutional investors and hedge funds own 7.58% of the company’s stock.

Retractable Technologies Company Profile

Retractable Technologies, Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. The company offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes.